BridgeBio have significantly boosted this development of an novel treatment for amyloid heart disease, leveraging the compound. Preliminary trial information indicates potential improvements for those affected with the https://bridgebio559349.mpeblog.com/76479382/firm-advances-attr-cm-therapy-through-the-therapy